These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 16940388

  • 1. Improvement in coronary vascular dysfunction produced with euglycaemic control in patients with type 2 diabetes.
    Schindler TH, Facta AD, Prior JO, Cadenas J, Hsueh WA, Quinones MJ, Schelbert HR.
    Heart; 2007 Mar; 93(3):345-9. PubMed ID: 16940388
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Effects of the combined treatment with Metformin/Glimepiride on endothelial function of patients with type 2 diabetes mellitus. A positron emission tomography (PET) evaluation study].
    Alexánderson-Rosas E, de Jesús Martínez A, Ochoa-López JM, Calleja-Torres R, Sierra-Fernández C, Iñarra-Talboy F, Meave-González A, Alexánderson-Rosas G, González-Canudas J.
    Arch Cardiol Mex; 2009 Mar; 79(4):249-56. PubMed ID: 20191984
    [Abstract] [Full Text] [Related]

  • 4. Dysregulation of coronary microvascular reactivity in asymptomatic patients with type 2 diabetes mellitus.
    Momose M, Abletshauser C, Neverve J, Nekolla SG, Schnell O, Standl E, Schwaiger M, Bengel FM.
    Eur J Nucl Med Mol Imaging; 2002 Dec; 29(12):1675-9. PubMed ID: 12458403
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Metformin improves skin capillary reactivity in normoglycaemic subjects with the metabolic syndrome.
    Kraemer de Aguiar LG, Laflor CM, Bahia L, Villela NR, Wiernsperger N, Bottino DA, Bouskela E.
    Diabet Med; 2007 Mar; 24(3):272-9. PubMed ID: 17263761
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cardiovascular, metabolic and hormonal responses to the progressive exercise performed to exhaustion in patients with type 2 diabetes treated with metformin or glyburide.
    Cunha MR, Silva ME, Machado HA, Fukui RT, Correia MR, Santos RF, Wajchenberg BL, Rocha DM, Rondon MU, Negrão CE, Ursich MJ.
    Diabetes Obes Metab; 2008 Mar; 10(3):238-45. PubMed ID: 18269639
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Elevated endocannabinoid plasma levels are associated with coronary circulatory dysfunction in obesity.
    Quercioli A, Pataky Z, Vincenti G, Makoundou V, Di Marzo V, Montecucco F, Carballo S, Thomas A, Staub C, Steffens S, Seimbille Y, Golay A, Ratib O, Harsch E, Mach F, Schindler TH.
    Eur Heart J; 2011 Jun; 32(11):1369-78. PubMed ID: 21303779
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.